These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Expression of transglutaminase activity in developing human epidermis. Akiyama M; Smith LT; Shimizu H Br J Dermatol; 2000 Feb; 142(2):223-5. PubMed ID: 10730752 [TBL] [Abstract][Full Text] [Related]
5. Application of non-radiolabeled in situ hybridization system for the detection of polyadenylated RNA to normal and psoriatic human skin. Masunaga T; Takahashi S; Shimizu H; Nishikawa T J Dermatol Sci; 1996 Sep; 12(3):227-31. PubMed ID: 8884527 [TBL] [Abstract][Full Text] [Related]
6. Localization of annexin I (lipocortin I, p35) mRNA in normal and diseased human skin by in situ hybridization. Sato-Matsumura KC; Koizumi H; Matsumura T; Ohkawara A; Takasu T; Furuta Y; Sawa H; Nagashima K Arch Dermatol Res; 1996 Sep; 288(10):565-9. PubMed ID: 8919037 [TBL] [Abstract][Full Text] [Related]
8. Elevated transglutaminase-2 expression in the epidermis of psoriatic skin and its role in the skin lesion development. Su CC; Su TR; Lai JC; Tsay GJ; Lin HK J Dermatol; 2017 Jun; 44(6):699-702. PubMed ID: 28150335 [TBL] [Abstract][Full Text] [Related]
9. Identification of mRNA-rich keratinocytes in the basal/suprabasal layers of psoriatic skin. Yokota K; Matsue H; Shibaki A; Kawashima T; Kobayashi H; Ohkawara A J Dermatol; 1996 Dec; 23(12):858-62. PubMed ID: 9037916 [TBL] [Abstract][Full Text] [Related]
10. Expression of keratinocyte transglutamine mRNA revealed by in situ hybridization. Michel S; Bernerd F; Jetten AM; Floyd EE; Shroot B; Reichert U J Invest Dermatol; 1992 Mar; 98(3):364-8. PubMed ID: 1347556 [TBL] [Abstract][Full Text] [Related]
11. Expression of transglutaminase 5 in normal and pathologic human epidermis. Candi E; Oddi S; Paradisi A; Terrinoni A; Ranalli M; Teofoli P; Citro G; Scarpato S; Puddu P; Melino G J Invest Dermatol; 2002 Sep; 119(3):670-7. PubMed ID: 12230511 [TBL] [Abstract][Full Text] [Related]
12. Precocious appearance of involucrin and epidermal transglutaminase during differentiation of psoriatic skin. Bernard BA; Reano A; Darmon YM; Thivolet J Br J Dermatol; 1986 Mar; 114(3):279-83. PubMed ID: 2869777 [TBL] [Abstract][Full Text] [Related]
13. In vivo transglutaminase type 1 expression in normal lung, preinvasive bronchial lesions, and lung cancer. Martinet N; Bonnard L; Regnault V; Picard E; Burke L; Siat J; Grosdidier G; Martinet Y; Vignaud JM Am J Respir Cell Mol Biol; 2003 Apr; 28(4):428-35. PubMed ID: 12654631 [TBL] [Abstract][Full Text] [Related]
14. Expression of plasminogen activator inhibitor type 2 in normal and psoriatic epidermis. Lyons-Giordano B; Loskutoff D; Chen CS; Lazarus G; Keeton M; Jensen PJ Histochemistry; 1994 Feb; 101(2):105-12. PubMed ID: 8071082 [TBL] [Abstract][Full Text] [Related]
15. Keratinocyte transglutaminase in human skin and oral mucosa: cytoplasmic localization and uncoupling of differentiation markers. Ta BM; Gallagher GT; Chakravarty R; Rice RH J Cell Sci; 1990 Apr; 95 ( Pt 4)():631-8. PubMed ID: 1974551 [TBL] [Abstract][Full Text] [Related]
18. Induction of normal and psoriatic phenotypes in submerged keratinocyte cultures. Van Ruissen F; de Jongh GJ; Zeeuwen PL; Van Erp PE; Madsen P; Schalkwijk J J Cell Physiol; 1996 Aug; 168(2):442-52. PubMed ID: 8707880 [TBL] [Abstract][Full Text] [Related]
19. Use of monospecific antisera and cRNA probes to localize the major changes in keratin expression during normal and abnormal epidermal differentiation. Stoler A; Kopan R; Duvic M; Fuchs E J Cell Biol; 1988 Aug; 107(2):427-46. PubMed ID: 2458356 [TBL] [Abstract][Full Text] [Related]
20. Co-localization of COX-2, CYP4F8, and mPGES-1 in epidermis with prominent expression of CYP4F8 mRNA in psoriatic lesions. Stark K; Törmä H; Oliw EH Prostaglandins Other Lipid Mediat; 2006 Mar; 79(1-2):114-25. PubMed ID: 16516815 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]